| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,794 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,046 |
| 424/277.1 |
Cancer cell or component thereof |
385 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
970 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6846477 |
One dose vaccination with Mycoplasma hyopneumoniae |
Jan. 25, 2005 |
| 6846487 |
Therapeutic compositions for treating infection by Lawsonia spp. |
Jan. 25, 2005 |
| 6846488 |
Chimeric antigen-enterotoxin mucosal immunogens |
Jan. 25, 2005 |
| 6846652 |
Viral vectors having enhanced effectiveness with reduced virulence |
Jan. 25, 2005 |
| 6846905 |
Antigen constructs useful in the detection and differentiation of antibodies to HIV |
Jan. 25, 2005 |
| 6844011 |
Methods for inhibiting rejection of transplanted tissue |
Jan. 18, 2005 |
| 6844314 |
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
Jan. 18, 2005 |
| 6841155 |
Immunization against and treatment for infection by H. pylori |
Jan. 11, 2005 |
| 6841156 |
Method for treating muscle spasm with botulinum toxin type B |
Jan. 11, 2005 |
| 6841157 |
Production of chimeric human papillomavirus |
Jan. 11, 2005 |
| 6841158 |
Recombinant celo virus and celo virus DNA |
Jan. 11, 2005 |
| 6841159 |
Rapid lateral flow assay for determining exposure to Mycobacterium tuberculosis and other mycobacteria |
Jan. 11, 2005 |
| 6841160 |
Meningococcal vaccines formulated with interleukin-12 |
Jan. 11, 2005 |
| 6841168 |
Method for the preservation of biologically-active material |
Jan. 11, 2005 |
| 6841358 |
RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF BORDETELLA, PARTICULARLY BORDETELLA PERTUSSIS, METHOD FOR PRODUCING SAME, AND USES THEREOF FOR PRODUCING FOREIGN PROTEINS OF VACCINATING A |
Jan. 11, 2005 |
| 6841386 |
Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein |
Jan. 11, 2005 |
| 6838247 |
Test for lyme disease |
Jan. 4, 2005 |
| 6838269 |
Proteins producing an altered immunogenic response and methods of making and using the same |
Jan. 4, 2005 |
| 6835381 |
Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor |
Dec. 28, 2004 |
| 6835384 |
Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains |
Dec. 28, 2004 |
| 6835818 |
Mutants of Streptococcal toxin C and methods of use |
Dec. 28, 2004 |
| 6833134 |
Immunization of dairy cattle with GapC protein against Streptococcus infection |
Dec. 21, 2004 |
| 6833136 |
Vaccine for preventing pythiosis in humans and animals |
Dec. 21, 2004 |
| 6833356 |
Pneumococcal protein homologs and fragments for vaccines |
Dec. 21, 2004 |
| 6827936 |
Synthetic peptide vaccines for dental caries |
Dec. 7, 2004 |
| 6824768 |
Ribavirin-pegylated interferon alfa induction HCV combination therapy |
Nov. 30, 2004 |
| 6824793 |
Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
Nov. 30, 2004 |
| 6821517 |
Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
Nov. 23, 2004 |
| 6821518 |
Compounds and methods for therapy and diagnosis of lung cancer |
Nov. 23, 2004 |
| 6821521 |
Multicomponent meningococcal vaccine |
Nov. 23, 2004 |
| 6821522 |
Tumor Therapy |
Nov. 23, 2004 |
| 6821723 |
GP41 antigen |
Nov. 23, 2004 |
| 6822070 |
Truncated CRAF1 inhibits CD40 signaling |
Nov. 23, 2004 |
| 6818217 |
Immunoreactive peptides |
Nov. 16, 2004 |
| 6818218 |
Prevention and treatment of amyloidogenic disease |
Nov. 16, 2004 |
| 6818223 |
Abundant extracellular products and methods for their production and use |
Nov. 16, 2004 |
| 6818442 |
AIDS DNA vaccine that prevents SIVmac239 virus infection in monkeys |
Nov. 16, 2004 |
| 6818628 |
Polynucleotide vaccine formula in particular against bovine respiratory pathology |
Nov. 16, 2004 |
| 6814971 |
Adjuvants for use in vaccines |
Nov. 9, 2004 |
| 6815169 |
Identification and expression of a novel kinesin motor protein |
Nov. 9, 2004 |
| 6811781 |
Composition and method for diagnosing auto-immune hepatitis |
Nov. 2, 2004 |
| 6811787 |
Over-expressing homologous antigen vaccine and a method of making the same |
Nov. 2, 2004 |
| 6808704 |
Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
Oct. 26, 2004 |
| 6808710 |
Downmodulating an immune response with multivalent antibodies to PD-1 |
Oct. 26, 2004 |
| 6808711 |
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines |
Oct. 26, 2004 |
| 6808713 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Oct. 26, 2004 |
| 6808714 |
Detection of sarcocystis neurona |
Oct. 26, 2004 |
| 6808877 |
Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection |
Oct. 26, 2004 |
| 6805862 |
Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
Oct. 19, 2004 |
| 6806055 |
HIV envelopolype peptides |
Oct. 19, 2004 |
|
|
|
